Dual GIP/GLP-1 Receptor Agonist | Metabolic & Glucose Regulation Research Compound

For Research Use Only. Not for human or veterinary use. Not a drug, supplement, or food additive.

Intended exclusively for in-vitro and laboratory research by qualified investigators.

Tirzepatide – 10mg / 20mg / 30mg
A Dual GIP and GLP-1 Receptor Agonist for Advanced Metabolic Research

Category: Peptide Research Compounds / Metabolic Research / Incretin Biology

Disclaimer

ATTENTION: PrimalResearchLabs.com products are intended for laboratory research and in-vitro studies only. All information presented is for educational and research purposes related to scientific investigation. These products are strictly not for human or veterinary use, consumption, or diagnostic applications.

They are not pharmaceuticals, food additives, or dietary supplements. By purchasing from PrimalResearchLabs.com, you acknowledge that you are a qualified researcher operating in a controlled laboratory environment.

Adhere to all applicable local, state, and federal laws and regulations regarding handling and use of research chemicals. Use appropriate personal protective equipment (PPE) and follow laboratory safety protocols.

Biology

Tirzepatide is a synthetic peptide engineered as a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual incretin mechanism enables coordinated modulation of glucose metabolism, insulin secretion, and energy balance.

Extensively studied in preclinical and clinical research models, Tirzepatide has demonstrated the ability to improve glycemic control, enhance insulin sensitivity, and reduce body weight through both peripheral and central mechanisms. Its dual-receptor activity makes it a valuable tool for in-vitro and in-vivo experimental design across diabetes research, obesity studies, and incretin signaling pathways.

This product is intended solely for in-vitro and preclinical research use and is not for human or veterinary consumption.

Key Research Applications of Tirzepatide

1. Dual Incretin Receptor Signaling & Glucose Regulation

Tirzepatide demonstrates significant activity in metabolic studies through:

• GLP-1 & GIP Receptor Activation: Enhances insulin secretion and improves glucose homeostasis.
• Glucose-Dependent Insulin Release: Supports physiologic insulin response to elevated glucose levels.
• Incretin Pathway Synergy: Combines dual hormone signaling for enhanced metabolic effects.

Supporting Studies:
Frias, J.P. et al. — New England Journal of Medicine
“Tirzepatide demonstrated dose-dependent improvements in glycemic control in type 2 diabetes.” ■ PubMed – PMID: 34170647

2. Weight Regulation & Energy Balance

Investigated in obesity and metabolic studies through:

• Appetite Suppression: Reduces food intake via central nervous system pathways.
• Energy Balance Modulation: Influences caloric intake and metabolic efficiency.
• Weight Reduction Mechanisms: Demonstrates significant reductions in body weight in experimental models.

Supporting Studies:
Jastreboff, A.M. et al. — New England Journal of Medicine
“Tirzepatide resulted in substantial and sustained reductions in body weight.” ■ PubMed – PMID: 35658024

3. Insulin Sensitivity & Metabolic Function

Explored in broader metabolic studies through:

• Insulin Sensitivity Enhancement: Improves cellular response to insulin signaling.
• Lipid Metabolism Regulation: Influences triglyceride and cholesterol pathways.
• Metabolic Syndrome Research: Applied in studies examining combined metabolic dysfunction.

Supporting Studies:
Coskun, T. et al. — Molecular Metabolism
“Dual GIP and GLP-1 receptor agonism improves metabolic outcomes and insulin sensitivity.” ■ PubMed – PMID: 27777923

Recommended Research Concentrations

For laboratory research reference only. Not for human or veterinary use.

Why Choose Primal Research for Your Tirzepatide Studies?

• ≥98% HPLC-verified purity — critical for dual receptor binding and metabolic pathway studies
• Independent third-party batch testing with COA available on request
• Lyophilized powder for maximum stability and long-term storage
• Available in 10mg, 20mg, and 30mg quantities — supports scalable metabolic research protocols

Storage & Handling

• Store at -20°C, desiccated and protected from light
• Soluble in sterile water or bacteriostatic water
• Prepare fresh solutions prior to each experiment
• Avoid repeated freeze-thaw cycles

Technical Specifications

• Compound: Tirzepatide
• Molecular Weight: ~4813 g/mol
• Purity: ≥98% (HPLC Verified)
• Form: Lyophilized powder — 10mg, 20mg, and 30mg
• Storage: -20°C, desiccated, light-protected
• Solubility: Soluble in sterile or bacteriostatic water
• COA: Available per batch on request

Advance Your Metabolic Research

Order your Tirzepatide today to support advanced research in incretin biology, glucose regulation, and metabolic disease modeling.

Primal Research products are sold strictly for in-vitro and laboratory research use only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease or condition. Purchasers are responsible for compliance with all applicable local, state, and federal regulations.